Oncotelic Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $23.7M
Liabilities Breakdown FY2020
Total Liabilities: $11.9M
Asset Breakdown
Total Assets: $23.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $474.0K | 2.0% |
| Accounts Receivable | $19.7K | 0.1% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $21.1M | 89.0% |
| Intangible Assets | $873.2K | 3.7% |
| Other Assets | $1.2M | 5.2% |
Liabilities Breakdown
Total Liabilities: $11.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.9M | 16.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $10.0M | 83.7% |